These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32444911)

  • 1. ASO Author Reflections: Avoiding Mastectomy: The Benefit of Neoadjuvant Chemotherapy for Large Unifocal Breast Tumors.
    Petruolo O; Barrio AV
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):755-756. PubMed ID: 32444911
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Bilateral Mastectomy After Neoadjuvant Therapy: An Ever-Increasing Trend?
    Kantor O; Yao K
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):650-651. PubMed ID: 30327968
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Residual Disease in the Breast After Neoadjuvant Chemotherapy Does Not Mandate Routine Post-Mastectomy Radiation Therapy/Regional Nodal Irradiation.
    Crown A; Morrow M
    Ann Surg Oncol; 2021 Mar; 28(3):1336-1337. PubMed ID: 32920718
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: The Role of Imaging Modalities in Omitting Surgery in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Palshof FK; Kroman N; Tvedskov TF
    Ann Surg Oncol; 2021 Nov; 28(12):7430-7431. PubMed ID: 34023947
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Postmastectomy Radiotherapy for Breast Cancer Patients After Neoadjuvant Chemotherapy, by Molecular Subtype.
    Ma JC; Zhong XR; Luo T; Liu L
    Ann Surg Oncol; 2021 Sep; 28(9):5096-5097. PubMed ID: 33604825
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: The Case for Using Response to Neoadjuvant Chemotherapy to Guide Administration of Post-mastectomy Radiation.
    Manik R; Fayanju OM
    Ann Surg Oncol; 2023 Oct; 30(11):6516-6517. PubMed ID: 37493891
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Neoadjuvant Chemotherapy Does Not Affect Short-Term Outcomes After Breast Cancer Surgery.
    Konishi T; Fujiogi M; Tanabe M; Seto Y; Yasunaga H
    Ann Surg Oncol; 2022 May; 29(5):3011-3012. PubMed ID: 34997419
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Preoperative Prediction of Postmastectomy Radiation Therapy After Neoadjuvant Systemic Therapy.
    Samiei S; Smidt ML; van Nijnatten TJA
    Ann Surg Oncol; 2019 Nov; 26(12):3910-3911. PubMed ID: 31485820
    [No Abstract]   [Full Text] [Related]  

  • 9. ASO Author Reflections: How Can We Eliminate Breast Surgery in Patients Who Achieved Clinical Complete Response After Neoadjuvant Chemotherapy?
    Sawaki M; Kataoka A
    Ann Surg Oncol; 2023 Jun; 30(6):3233-3234. PubMed ID: 36765007
    [No Abstract]   [Full Text] [Related]  

  • 10. ASO Author Reflections: Neoadjuvant Chemotherapy for Breast Cancer May Not Alter Increasing Trends for CPM Utilization.
    Christian N; Gemignani ML
    Ann Surg Oncol; 2020 Mar; 27(3):750-751. PubMed ID: 31728793
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Nipple-Sparing Mastectomy Increasingly Utilized for Patients with Locally Advanced Disease Who Demonstrate Response to Neoadjuvant Chemotherapy.
    Wong SM; Erdmann-Sager J
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):849-850. PubMed ID: 31749077
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Nodal Downstaging and Conversion to Breast-Conserving Surgery Following Neoadjuvant Endocrine Therapy.
    Montagna G; Morrow M; Pilewskie M
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):693-694. PubMed ID: 32797378
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: Postmastectomy Radiation Therapy: Focus on Triple-Negative Breast Cancer.
    Abi Jaoude J; Zeidan YH
    Ann Surg Oncol; 2022 Jan; 29(1):467-468. PubMed ID: 34480286
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer.
    Andrianello S; Marchegiani G; Salvia R
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):810-811. PubMed ID: 30374921
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Avoiding Overtreatment: Benefits of Selective Use of Frozen Sections Among cN0 Breast Cancer Patients Having Upfront Mastectomy.
    Williams AD; Mamtani A
    Ann Surg Oncol; 2022 Dec; 29(13):8044-8045. PubMed ID: 35974234
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: Oncoplastic Surgery Facilitates Breast Conservation and May Permit More Judicious Chemotherapy Use.
    Crown A; Rocha FG; Grumley J
    Ann Surg Oncol; 2021 Apr; 28(4):2210-2211. PubMed ID: 32935265
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: Disparities in Outcome and Surgical Management Following Neoadjuvant Chemotherapy for Breast Cancer.
    Relation T; Oppong BA
    Ann Surg Oncol; 2021 Oct; 28(11):6498-6499. PubMed ID: 33660126
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: Selecting Patients for Elimination of Surgery Trials-Predicting Residual Invasive and In Situ Disease in Patients with HER2-Positive Breast Cancer After Neoadjuvant Systemic Therapy.
    Sun SX; Kuerer HM
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):804-805. PubMed ID: 31654165
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: Limiting Axillary Surgery for Microinvasive Breast Cancer.
    James TA; Fan B
    Ann Surg Oncol; 2020 Oct; 27(11):4474. PubMed ID: 32488515
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: Sequencing of Breast Surgery and Chemotherapy Does Not Impact Patient-Reported Outcomes.
    Pawloski KR; Tadros AB
    Ann Surg Oncol; 2023 May; 30(5):2910-2911. PubMed ID: 36792767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.